Pfizer Inc. (PFE) Completed Acquisition of FoldRx Pharmaceuticals, Inc.
10/6/2010 10:41:38 AM
More...
|
Pfizer Inc. (PFE) to Acquire FoldRx Pharmaceuticals, Inc. for Undisclosed Amount, Looks to Expand Developmental Pipeline
9/1/2010 6:48:41 AM
More...
|
FoldRx Pharmaceuticals, Inc. Secures $29 Million Financing
6/15/2010 7:17:03 AM
More...
|
FoldRx Pharmaceuticals, Inc. Appoints Dr. Georges Gemayel as Executive Chairman
5/5/2010 9:39:45 AM
More...
|
FoldRx Pharmaceuticals, Inc. to Present at the American Academy of Neurology Annual Meeting
4/14/2010 9:38:44 AM
More...
|
FoldRx Pharmaceuticals, Inc. Promising First-in-class Drug Candidate For Genetic Protein-misfolding Disease, The Scripps Research Institute Study
7/23/2009 7:55:11 AM
More...
|
FoldRx Pharmaceuticals, Inc. Announces Positive Results from Pivotal Phase II/III Clinical Study of Tafamidis
7/21/2009 9:53:34 AM
More...
|
William Aliski Named FoldRx Pharmaceuticals, Inc. Chief Commercial Officer
6/9/2009 9:23:21 AM
More...
|
FoldRx Pharmaceuticals, Inc. to Raise Awareness of TTR Amyloidosis in Conjunction with NORD’s Rare Diseases Day
2/26/2009 12:57:10 PM
More...
|
FoldRx Pharmaceuticals, Inc. Release: New Research of Amyloid Cardiomyopathy Fosters Better Understanding of Disease Progression
11/11/2008 10:23:21 AM
More...
|
|